Hudson Bay Capital Management LP 13D/13G Filings for InMed Pharmaceuticals Inc. (INM)

Hudson Bay Capital Management LP 13D and 13G filings for InMed Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-04
3:29 pm
Purchase
2021-12-3113GINMED PHARMACEUTICALS INC
INM
Hudson Bay Capital Management LP1,120
3.810%
231increase
(+25.98%)
Filing